Back to results
US 2019/0240222 A1Published application
Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas
AssigneeCelgene Corporation
InventorsJiangchun Xu, Robert Cho, Aaron Nguyen
Life of this patent
Estimating the term…
Abstract
Methods are provided for the treatment of relapsed and/or refractory solid tumors (including neuroendocrine carcinomas (NEC)) and non-Hodgkin's lymphomas (NHLs) and the like, using substituted heterocyclic derivative compounds and pharmaceutical compositions comprising compounds useful for the inhibition of lysine specific demethylase-1 (LSD-1).
Claims5
A method for the treatment of small cell lung cancer comprising the administration to a patient in need thereof an effective amount of a compound having the structure of:
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.